OmniStar Financial Group’s Cardinal Health CAH Stock Holding History

OmniStar Financial Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,015	Closed	-$285K	–	123
2021 Q2	$285K	Buy	+5,015	New	+$293K	0.35%	87

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OmniStar Financial Group's CAH Position: Q3 2022 in Review

OmniStar Financial Group sold out of Cardinal Health (CAH) in Q3 2022, closing a stake of 5,714 shares — an estimated $298K sold.

OmniStar Financial Group first reported a position in CAH in Q1 2020 and held it in 9 quarters. The position peaked at $626K in Q4 2020. 849 funds tracked by Wall St. Rank hold CAH as of Q3 2022.

OmniStar Financial Group reported no remaining Cardinal Health position as of Q3 2022 after selling out during the quarter.
OmniStar Financial Group sold 5,714 Cardinal Health shares in Q3 2022, an estimated $298K.
OmniStar Financial Group first reported a position in Cardinal Health in Q1 2020 and held it in 9 quarters.
OmniStar Financial Group's Cardinal Health position peaked at $626K in Q4 2020.
849 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2022.

Based on OmniStar Financial Group's 13F filing for Q3 2022, filed 14 Nov 2022.